IP Library Patent Application 12505457
Patent Application
App. No. 12/505,457

LONG-ACTING INJECTABLE ANALGESIC FORMULATIONS FOR ANIMALS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/505,457
Abstract

Long acting injectable analgesic formulations and methods for providing long lasting pain relief in animals are disclosed.

Claims (10)

1 . A long-acting injectable formulation comprising an analgesic, a polyorthoester and optionally a pharmaceutically acceptable excipient or carrier.

2 . The formulation of claim 1 , wherein the analgesic is selected from the group consisting of opioid agonists, opioid antagonists, non-opioid analgesics and mixtures thereof.

3 . The formulation of claim 2 , wherein the analgesic is buprenorphine or a pharmaceutically acceptable salt or hydrate thereof.

4 . The formulation of claim 3 , wherein the polyorthoester is prepared by a reaction between 3,9-di(ethylidene)-2,4,8,10-tetraoxaspiro[5.5]undecane (DETOSU), triethylene glycol (TEG) and triethyleneglycol monoglycolide (TEG-mGL).

5 . The formulation of claim 3 , wherein the polyorthoester is prepared by a condensation reaction between one or more diols and a diketene acetal.

6 . The formulation of claim 3 , wherein the polyorthoester is treated under conditions selected from the group consisting of an elevated temperature, an inert gas, reduced oxygen concentration, reduced humidity, elevated or reduced pressure, elevated or reduced mixing speed, a sufficient treatment time, and a combination thereof.

7 . The formulation of claim 3 , wherein the polyorthoester is selected from the group consisting of APF 579, APF 579R, APF 580, APF 580R, APF 626, APF 626R, and a mixture thereof.

8 . The formulation of claim 3 , wherein the dosage of opioid agonist has a range selected from the group consisting of about 0.01—about 1.0 mg/kg; about 0.025—about 0.5 mg/kg; about 0.75—about 0.4 mg/kg; and about 0.1 mg/kg—about 0.4 mg/kg.

9 . A method for providing long lasting pain relief in an animal comprising administering to the animal any one of the formulations of claims 1 - 8 .

10 . The method of claim 9 , wherein the pain relief is for a period of time selected from the group consisting of about 12 hours to about 48 hours, about 24 hours to about 72 hours, about 3 to 5 days, about 5 days to about 7 days and about 7 days to about 10 days.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026177/FRAME 0874 Recorded Sep 27, 2023
From: TANG CAPITAL PARTNERS, LP
To: HERON THERAPEUTICS, INC. (F/K/A A.P. PHARMA, INC.)
Reel/Frame 065045/0730 →
CHANGE OF NAME Recorded Feb 3, 2014
From: A.P. PHARMA, INC.
To: HERON THERAPEUTICS, INC.
Reel/Frame 032153/0273 →
SECURITY AGREEMENT Recorded Apr 25, 2011
From: A.P. PHARMA, INC.
To: TANG CAPITAL PARTNERS, LP, AS AGENT
Reel/Frame 026177/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2010
From: BARR, JOHN
To: AP PHARMA
Reel/Frame 023801/0718 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2010
From: HANSON, PETER; ROSENTEL, JOSEPH K.
To: MERIAL LIMITED
Reel/Frame 023801/0731 →